hPD-1(3)
Nomenclature
C57BL/6JSmo-Pdcd1tm2(hPDCD1)Smoc
Cat. NO.
NM-HU-235087
Strain State
Repository Live
Gene Summary
Gene Symbol
Pdcd1
Model Description
Validation Data

Fig.1 Detection of PDCD1 expression in spleen by RT-PCR. Spleen RNA was extracted from 7-week-old female wild-type C57BL/6 (WT)(n=2) and homozygous hPD-1(3) knockin mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. Mouse Pdcd1 mRNA (187 bp) was detectable only in wild-type C57BL/6 mice. Human PDCD1 mRNA (137 bp) was detectable only in homozygous hPD-1(3) knockin mice but not in wild-type mice.

Fig.2 Detection of PDCD1 expression in spleen by qPCR. H/M Pdcd1 mRNA was detectable both in wild-type mice and homozygous hPD-1(3) knockin mice. Spleen RNA was extracted from 7-week-old female wild-type C57BL/6 (WT)(n=2) and homozygous hPD-1(3) knockin mice (HO) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by qPCR with h/m Pdcd1 and mouse Gapdh primers. Relative expression represents the h/m Pdcd1 mRNA level relative to its average expression in homozygous hPD-1(3) knockin mice.

Fig.3 Human and mouse PD-1 expression on T cells from WT C57BL/6 and HO hPD-1 homozygous mice. Splenocytes were gated on CD3⁺ or CD4⁺ T cells and analyzed by flow cytometry with anti-human PD-1and anti-mouse PD-1. Flow cytometric analysis shows that human PD‑1 is expressed on CD3⁺ and CD4⁺ T cells in HOhPD-1 mice , while WT C57BL/6 mice lack human PD‑1 expression, confirming successful humanization of the Pdcd1 locus.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more